Wentao Xu

EPHA5 mutation predicts the durable clinical benefit of immune checkpoint inhibitors in patients with lung adenocarcinoma

Yuchen Liu, Jian Zhang, Qingwen Lyu, 2020, Cancer Gene Therapy.

A Signature Based on Costimulatory Molecules for the Assessment of Prognosis and Immune Characteristics in Patients With Stomach Adenocarcinoma

Lizhi Zhang, Xinyi Wang, Chenyu Sun, 2022, Frontiers in Immunology.

Mutations Status of Chemokine Signaling Pathway Predict Prognosis of Immune Checkpoint Inhibitors in Colon Adenocarcinoma

Jian Zhang, P. Luo, Anqi Lin, 2021, Frontiers in Pharmacology.

A Pan-Cancer Analysis of the Oncogenic Role of Cell Division Cycle-Associated Protein 4 (CDCA4) in Human Tumors

Yuchen Liu, Lizhi Zhang, Xinyi Wang, 2022, Frontiers in Immunology.

Characterization of aberrant pathways activation and immune microenviroment of BK virus associated nephropathy

Yuzhu Li, Ding Liu, Liu-yang Li, 2020, Aging.